JP7240565B2 - Ｌ－エルゴチオネイン含有組成物 - Google Patents

Ｌ－エルゴチオネイン含有組成物 Download PDF

Info

Publication number
JP7240565B2
JP7240565B2 JP2022549575A JP2022549575A JP7240565B2 JP 7240565 B2 JP7240565 B2 JP 7240565B2 JP 2022549575 A JP2022549575 A JP 2022549575A JP 2022549575 A JP2022549575 A JP 2022549575A JP 7240565 B2 JP7240565 B2 JP 7240565B2
Authority
JP
Japan
Prior art keywords
mass
parts
srh
egt
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022549575A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022220123A5 (https=
JPWO2022220123A1 (https=
Inventor
淳 松本
豪 仲谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagase and Co Ltd
Original Assignee
Nagase and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagase and Co Ltd filed Critical Nagase and Co Ltd
Publication of JPWO2022220123A1 publication Critical patent/JPWO2022220123A1/ja
Publication of JPWO2022220123A5 publication Critical patent/JPWO2022220123A5/ja
Application granted granted Critical
Publication of JP7240565B2 publication Critical patent/JP7240565B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
JP2022549575A 2021-04-14 2022-03-30 Ｌ－エルゴチオネイン含有組成物 Active JP7240565B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021068583 2021-04-14
JP2021068583 2021-04-14
PCT/JP2022/015935 WO2022220123A1 (ja) 2021-04-14 2022-03-30 Ｌ－エルゴチオネイン含有組成物

Publications (3)

Publication Number Publication Date
JPWO2022220123A1 JPWO2022220123A1 (https=) 2022-10-20
JPWO2022220123A5 JPWO2022220123A5 (https=) 2023-03-14
JP7240565B2 true JP7240565B2 (ja) 2023-03-15

Family

ID=83639633

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549575A Active JP7240565B2 (ja) 2021-04-14 2022-03-30 Ｌ－エルゴチオネイン含有組成物

Country Status (5)

Country Link
US (1) US20240189283A1 (https=)
EP (1) EP4324336B1 (https=)
JP (1) JP7240565B2 (https=)
CN (1) CN117042631A (https=)
WO (1) WO2022220123A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019163767A1 (ja) 2018-02-23 2019-08-29 長瀬産業株式会社 エルゴチオネインの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707087B1 (fr) * 1993-06-28 1995-10-13 Bioxytech Nouveau procédé de préparation de l'ergothionéine.
US10167490B2 (en) * 2012-12-21 2019-01-01 Ergo Health Llc Ergothioneine production through metabolic engineering
WO2019089878A1 (en) 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019163767A1 (ja) 2018-02-23 2019-08-29 長瀬産業株式会社 エルゴチオネインの製造方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HALLIDAY, N. M. et al.，Quantitative liquid chromatography-tandem mass spectrometry profiling of activated methyl cycle meta，Analytical Biochemistry，2010年，403，20-29

Also Published As

Publication number Publication date
EP4324336A4 (en) 2025-03-26
US20240189283A1 (en) 2024-06-13
WO2022220123A1 (ja) 2022-10-20
CN117042631A (zh) 2023-11-10
EP4324336B1 (en) 2026-04-01
JPWO2022220123A1 (https=) 2022-10-20
EP4324336A1 (en) 2024-02-21

Similar Documents

Publication Publication Date Title
JP5521788B2 (ja) 新規なレスベラトロール重合化合物又はその薬学的に許容可能な塩
US12357614B2 (en) L-ergothioneine-containing composition
JP2011032171A (ja) 美白用組成物
JP2008239619A (ja) 末梢血行改善組成物
TW201343189A (zh) 含牛蒡苷元衍生物之抗老化劑
JP4828922B2 (ja) 抗アレルギー剤
US7622450B2 (en) Flavone C-glycoside derivatives and compositions containing the derivatives
JPWO2015083554A1 (ja) ４Ｇ−Ｏ−α−Ｄ−グルコピラノシルルチンの結晶とその用途
JP7240565B2 (ja) Ｌ－エルゴチオネイン含有組成物
JP7727671B2 (ja) ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
KR101767261B1 (ko) 메이스리그난 또는 육두구 추출물을 유효성분으로 하는 가려움증 완화 또는 피부손상 개선용 조성물
BR122023019667B1 (pt) Método de produção de uma composição contendo l-ergotioneína e n, n-dimetil-l-2-tiohistidina e método de supressão de coloração da composição
HK40075066A (en) L-ergothioneine-containing composition
BR112022017415B1 (pt) Composição contendo l-ergotioneína
TWI918846B (zh) 升半胱胺酸衍生物及其製造方法、組成物、以及發炎抑制劑
KR20150019678A (ko) 피부 미백용 조성물
JP2019520786A (ja) ３−ｏ−ガロイル−３，３’，５，５’，７−ペンタヒドロキシフラボンを含む保湿用組成物
KR20250118230A (ko) 에리스리톨을 포함하는 기억력 향상용 또는 기억 장애 질환 치료용 조성물
JP5798289B2 (ja) 異常蛋白質除去用組成物
CN116648231A (zh) 抗炎症剂
KR20150019675A (ko) 피부 미백용 조성물

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220818

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220818

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220818

RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20220825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20220825

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221228

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230301

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230303

R150 Certificate of patent or registration of utility model

Ref document number: 7240565

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250